| Name |
CAS |
Iterm |
Detail |
| Axitinib |
319460-85-0 |
Pharmaceutical intermediates |
Detail |
| BIBW 2992 |
439081-18-2 |
Pharmaceutical intermediates |
Detail |
| 3-CHLORO-4-METHOXYBENZYLAMINE HYDROCHLORIDE |
41965-95-1 |
Pharmaceutical intermediates |
Detail |
| 5-PyriMidinecarboxylic acid,4-[[(3-chloro-4-Methoxyphenyl)Methyl]aMino]-2-[(2S)-2-(hydroxyMethyl)-1-pyrrolidinyl]-, ethyl ester |
330785-83-6 |
Pharmaceutical intermediates |
Detail |
| 5-PyriMidinecarboxylic acid, 4-[[(3-chloro-4-Methoxyphenyl)Methyl]aMino]-2-[(2S)-2-(hydroxyMethyl)- 1-pyrrolidinyl]- |
330785-84-7 |
Pharmaceutical intermediates |
Detail |
| (5-PyriMidinecarboxylicacid, 4-[[(3-chloro-4-Methoxyphenyl)Methyl]aMino]-2-(Methylthio)-,ethyl ester) |
330785-81-4 |
Pharmaceutical intermediates |
Detail |
| 4-(3-chloro-4-MethoxybenzylaMino)-5-ethoxycarbonyl-2-MethylsulfinylpyriMidine |
330785-82-5 |
Pharmaceutical intermediates |
Detail |
| Avanafil |
330784-47-9 |
Pharmaceutical intermediates |
Detail |
| 3-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-hydroxybenzenemethanol |
207679-81-0 |
Pharmaceutical intermediates |
Detail |
| Fesoterodinefumarate |
286930-03-8 |
Pharmaceutical intermediates |
Detail |
| 5-Fluoro-2-oxindole |
56341-41-4 |
Pharmaceutical intermediates |
Detail |
| 5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid |
253870-02-9 |
Pharmaceutical intermediates |
Detail |
| N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate |
341031-54-7 |
Pharmaceutical intermediates |
Detail |
| (S)-(-)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)propanamine |
132335-44-5 |
Pharmaceutical intermediates |
Detail |
| Duloxetine |
116539-59-4 |
Pharmaceutical intermediates |
Detail |
| 4-Hydroxyphenyl hydantoin |
2420-17-9 |
Pharmaceutical intermediates |
Detail |
| D-Hydroxyphenylglycine |
22818-40-2 |
Pharmaceutical intermediates |
Detail |
| Caronic anhydride |
67911-21-1 |
Pharmaceutical intermediates |
Detail |
| (4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone |
189028-93-1 |
Pharmaceutical intermediates |
Detail |
| Ezetimibe |
163222-33-1 |
Pharmaceutical intermediates |
Detail |
.jpg){kind=small}